Photo: 嘿嘿视频 Staff
In order to make big discoveries, scientists need to take big risks. Grant support from The Mark Foundation for Cancer Research is enabling , associate professor in the and a member of 嘿嘿视频 Health鈥檚 Perlmutter Cancer Center, to do just that. Working at the interface of biophysics and immunology, Dr. Krogsgaard and her colleagues are developing mice with humanized T cell receptors, which allow immune cells to recognize mutated proteins produced by tumors. Their research aims to develop improved cancer immunotherapies.
鈥淥ur research is aimed at improving current therapies,鈥 Dr. Krogsgaard tells The Mark Foundation blog. 鈥淲e hope to find ways to make these treatments better at fighting cancer while preventing some of the toxicities, as well as the resistance, that we often see with the therapies we have now.鈥
Read more from .
